Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial

Treatments for coronavirus disease 2019 (COVID-19) are limited by suboptimal efficacy. From January 30, 2020 to March 23, 2020, we conducted a non-randomised controlled trial, in which all adult patients with laboratory-confirmed COVID-19 were assigned to three groups non-randomly and given supporti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Phytomedicine (Stuttgart) 2021-01, Vol.81, p.153367-153367, Article 153367
Hauptverfasser:	Shi, Nannan, Guo, Lanping, Liu, Bin, Bian, Yongjun, Chen, Renbo, Chen, Suping, Chen, Yang, Chen, Yingying, Cong, Xiaodong, Dong, Guoju, Guo, Jing, Hu, Lijie, Jiang, Jianxin, Leng, Luxing, Li, Bin, Li, Dongxu, Li, Hao, Li, Jing, Li, Li, Liu, Jia, Lu, Cheng, Lv, Wenliang, Miao, Qing, Qi, Wensheng, Shi, Zhan, Shi, Jiaheng, Shi, Huaxin, Tian, Yaxin, Wang, Bing, Wang, Gang, Wang, Jian, Wang, Wei, Xian, Yongyue, Xie, Xiaolei, Xiong, Yibai, Xu, Chunyan, Xu, Ming, Yan, Bei, Yang, Jinliang, Zhang, Li, Zhou, Zhenqi, Zhu, Haoning, Huang, Luqi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Chinese herbal medicine Coronavirus disease 2019 COVID-19 - diagnostic imaging COVID-19 - drug therapy Drug Combinations Drug Therapy, Combination Drugs, Chinese Herbal - adverse effects Drugs, Chinese Herbal - therapeutic use Female Humans Lopinavir - adverse effects Lopinavir - therapeutic use Lopinavir-Ritonavir Male Medicine, Chinese Traditional Middle Aged Non-randomized controlled trial Patient Safety Prospective Studies Ritonavir - adverse effects Ritonavir - therapeutic use Thorax - diagnostic imaging Tomography, X-Ray Computed Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!